<it>Leishmania infantum HSP70-II</it> null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation
<p>Abstract</p> <p>Background</p> <p>Visceral leishmaniasis is the most severe form of leishmaniasis and no effective vaccine exists. The use of live attenuated vaccines is emerging as a promising vaccination strategy.</p> <p>Results</p> <p>In th...
Main Authors: | Fresno Manuel, Soto Manuel, Folgueira Cristina, Carrión Javier, Requena Jose M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-07-01
|
Series: | Parasites & Vectors |
Online Access: | http://www.parasitesandvectors.com/content/4/1/150 |
Similar Items
-
Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models.
by: José Carlos Solana, et al.
Published: (2017-05-01) -
Subcutaneous Immunization of <i>Leishmania HSP70-II</i> Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice
by: José Carlos Solana, et al.
Published: (2020-03-01) -
Inoculation of the <i>Leishmania infantum HSP70-II</i> Null Mutant Induces Long-Term Protection against <i>L. amazonensis </i>Infection in BALB/c Mice
by: Manuel Soto, et al.
Published: (2021-02-01) -
The <it>Leishmania infantum </it>PUF proteins are targets of the humoral response during visceral leishmaniasis
by: Requena Jose M, et al.
Published: (2010-01-01) -
Proteomic analysis of metacyclogenesis in Leishmania infantum wild-type and PTR1 null mutant
by: Wilfried Moreira, et al.
Published: (2014-09-01)